Status:

COMPLETED

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Lead Sponsor:

City of Hope Medical Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Breast Cancer

Eligibility:

FEMALE

20+ years

Brief Summary

RATIONALE: Collecting and storing samples of blood and tumor tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is stu...

Detailed Description

OBJECTIVES: Primary * To establish a specimen bank from peripheral blood specimens collected from women with a full spectrum of breast disease (invasive breast cancer \[IBC\], ductal or lobular carc...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Biopsy-confirmed diagnosis of one of the following:
  • Stage I-IV infiltrating ductal or infiltrating lobular carcinoma
  • Patients with early-stage disease must not have started systemic treatment; if no systemic treatment is planned, patients must be either preoperative or ≤ 120 days since definitive breast surgery
  • Patients with locally advanced disease must be scheduled for neoadjuvant chemotherapy prior to initiation of systemic treatment
  • Ductal carcinoma in situ
  • Lobular carcinoma in situ
  • Benign breast disease
  • Proliferative or non-proliferative
  • With or without atypia
  • PATIENT CHARACTERISTICS:
  • Karnofsky performance status 50-100%
  • Not pregnant
  • No prior invasive cancer diagnosis within the past 5 years except for squamous cell or basal cell carcinoma of the skin
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No prior systemic therapy (chemotherapy or hormonal therapy) for patients with stage I-III disease

Exclusion

    Key Trial Info

    Start Date :

    August 1 2005

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    June 6 2019

    Estimated Enrollment :

    563 Patients enrolled

    Trial Details

    Trial ID

    NCT00898508

    Start Date

    August 1 2005

    End Date

    June 6 2019

    Last Update

    June 25 2025

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Tower Cancer Research Foundation

    Beverly Hills, California, United States, 90211

    2

    City of Hope Comprehensive Cancer Center

    Duarte, California, United States, 91010-3000

    3

    City of Hope Medical Group

    Pasadena, California, United States, 91105